Skip to main content

Destructive tophaceous calcium hydroxyapatite tumor of the infratemporal fossa. Case report and review of the literature.

Publication ,  Journal Article
Grant, GA; Wener, MH; Yaziji, H; Futran, N; Bronner, MP; Mandel, N; Mayberg, MR
Published in: J Neurosurg
January 1999

Tophaceous pseudogout is one of the rarest forms of crystal deposition disease, typically presenting as a destructive and invasive mass involving the temporomandibular joint or the infratemporal fossa region in the absence of any other articular manifestations. Previous cases have been assumed to be caused by calcium pyrophosphate dihydrate (CPPD) crystal deposition, based on finding weakly birefringent crystals in the involved tissues. The authors present the unique case of a 65-year-old woman with a destructive and invasive facial mass extending to the middle cranial fossa with microscopic and clinical features consistent with tophaceous pseudogout. High-resolution x-ray crystallographic powder diffraction and Fourier transformed infrared spectroscopy subsequently revealed that the crystals were composed of calcium hydroxyapatite without CPPD. The patient was later found to have primary hyperparathyroidism and mild hypercalcemia. This case demonstrates that tissue deposits of calcium hydroxyapatite can cause a destructive and invasive mass containing weakly birefringent crystals and raises the question of whether previous cases attributed to tophaceous pseudogout resulting from CPPD actually were composed of birefringent calcium hydroxyapatite.

Duke Scholars

Published In

J Neurosurg

DOI

ISSN

0022-3085

Publication Date

January 1999

Volume

90

Issue

1

Start / End Page

148 / 152

Location

United States

Related Subject Headings

  • X-Ray Diffraction
  • Temporal Bone
  • Spectroscopy, Fourier Transform Infrared
  • Neurology & Neurosurgery
  • Hyperparathyroidism
  • Hypercalcemia
  • Humans
  • Female
  • Durapatite
  • Crystallography
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Grant, G. A., Wener, M. H., Yaziji, H., Futran, N., Bronner, M. P., Mandel, N., & Mayberg, M. R. (1999). Destructive tophaceous calcium hydroxyapatite tumor of the infratemporal fossa. Case report and review of the literature. J Neurosurg, 90(1), 148–152. https://doi.org/10.3171/jns.1999.90.1.0148
Grant, G. A., M. H. Wener, H. Yaziji, N. Futran, M. P. Bronner, N. Mandel, and M. R. Mayberg. “Destructive tophaceous calcium hydroxyapatite tumor of the infratemporal fossa. Case report and review of the literature.J Neurosurg 90, no. 1 (January 1999): 148–52. https://doi.org/10.3171/jns.1999.90.1.0148.
Grant GA, Wener MH, Yaziji H, Futran N, Bronner MP, Mandel N, et al. Destructive tophaceous calcium hydroxyapatite tumor of the infratemporal fossa. Case report and review of the literature. J Neurosurg. 1999 Jan;90(1):148–52.
Grant, G. A., et al. “Destructive tophaceous calcium hydroxyapatite tumor of the infratemporal fossa. Case report and review of the literature.J Neurosurg, vol. 90, no. 1, Jan. 1999, pp. 148–52. Pubmed, doi:10.3171/jns.1999.90.1.0148.
Grant GA, Wener MH, Yaziji H, Futran N, Bronner MP, Mandel N, Mayberg MR. Destructive tophaceous calcium hydroxyapatite tumor of the infratemporal fossa. Case report and review of the literature. J Neurosurg. 1999 Jan;90(1):148–152.

Published In

J Neurosurg

DOI

ISSN

0022-3085

Publication Date

January 1999

Volume

90

Issue

1

Start / End Page

148 / 152

Location

United States

Related Subject Headings

  • X-Ray Diffraction
  • Temporal Bone
  • Spectroscopy, Fourier Transform Infrared
  • Neurology & Neurosurgery
  • Hyperparathyroidism
  • Hypercalcemia
  • Humans
  • Female
  • Durapatite
  • Crystallography